Insider Selling: PACS Group (NYSE:PACS) CEO Sells 13,696 Shares of Stock

PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 13,696 shares of the stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $47.55, for a total value of $651,244.80. Following the sale, the chief executive officer directly owned 54,257,117 shares of the company's stock, valued at approximately $2,579,925,913.35. This trade represents a 0.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

  • On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total transaction of $3,349,366.20.
  • On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total transaction of $314,768.20.
  • On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total transaction of $1,785,779.05.
  • On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total transaction of $77,063.40.
  • On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
  • On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
  • On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total value of $10,440.00.
  • On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total value of $30,458.16.
  • On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75.
  • On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total transaction of $1,033,395.84.

PACS Group Trading Up 2.7%




Shares of PACS opened at $48.91 on Tuesday. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $49.78. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm's 50-day moving average price is $43.85 and its 200-day moving average price is $39.65. The firm has a market capitalization of $7.74 billion, a price-to-earnings ratio of 25.34, a PEG ratio of 1.49 and a beta of -0.08.

PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The company had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Sell-side analysts anticipate that PACS Group, Inc. will post 2.13 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its stake in PACS Group by 370.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company's stock worth $25,051,000 after acquiring an additional 614,250 shares during the period. Sei Investments Co. lifted its stake in shares of PACS Group by 7.4% during the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company's stock valued at $11,900,000 after buying an additional 25,462 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company's stock worth $9,274,000 after buying an additional 89,067 shares during the period. Bank of New York Mellon Corp bought a new position in PACS Group in the 2nd quarter worth $8,196,000. Finally, Corient Private Wealth LP increased its stake in PACS Group by 1.8% in the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company's stock worth $6,517,000 after buying an additional 2,680 shares in the last quarter.

Analyst Upgrades and Downgrades

PACS has been the subject of a number of analyst reports. UBS Group raised their price objective on PACS Group from $57.00 to $60.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. Royal Bank Of Canada lifted their target price on shares of PACS Group from $52.00 to $57.00 and gave the stock an "outperform" rating in a research report on Thursday, August 6th. Weiss Ratings upgraded shares of PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, October 8th. JPMorgan Chase & Co. raised their price target on PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research note on Friday, September 4th. Finally, Oppenheimer increased their target price on PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, PACS Group presently has an average rating of "Moderate Buy" and an average price target of $58.80.

Read Our Latest Research Report on PACS Group

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

Recommended Stories

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at PACS Group?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for PACS Group and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles